Morphea in two patients after being infected to and being vaccinated against SARS-CoV-2 infection

Zeinab Aryanian; Kamran Balighi; Parvaneh Hatami; Nasim Mazloumi Tootoonchi; Azadeh Goodarzi; Zeinab Mohseni Afshar

doi:10.1002/ccr3.5667

Morphea in two patients after being infected to and being vaccinated against SARS-CoV-2 infection

Clin Case Rep. 2022 Apr 18;10(4):e05667. doi: 10.1002/ccr3.5667. eCollection 2022 Apr.

Authors

Zeinab Aryanian^{1

2}, Kamran Balighi^{1

3}, Parvaneh Hatami¹, Nasim Mazloumi Tootoonchi^{1

3}, Azadeh Goodarzi^{4

5}, Zeinab Mohseni Afshar⁶

Affiliations

¹ Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran.
² Department of Dermatology Babol University of Medical Sciences Babol Iran.
³ Department of Dermatology Razi Hospital Tehran University of Medical Sciences Tehran Iran.
⁴ Department of Dermatology Rasoul-e-Akram Hospital Iran University of Medical Sciences Tehran Iran.
⁵ Skin and Stem Cell Research Center Tehran Iran.
⁶ Clinical Research Development Center Imam Reza Hospital Kermanshah University of Medical Sciences Kermanshah Iran.

Abstract

Although the presence of morphea following COVID-19 has been rarely reported, the development of its generalized form following COVID-19 vaccination has not been reported yet. Here, we reported the first case of generalized morphea following COVID-19 vaccination and another similar case following SARS-Cov-2 infection. Other etiologic factors were also dealt with.

Keywords: AstraZeneca; COVID; COVID vaccination; SARS‐Cov‐2; morphea.

Publication types

Case Reports